|
Volumn 5, Issue 20, 2013, Pages 9902-9907
|
Janus nanogels of PEGylated Taxol and PLGA-PEG-PLGA copolymer for cancer therapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICANCER DRUG;
BREAST CANCER MODELS;
CANCER THERAPY;
DELIVERY SYSTEMS;
ENHANCED UPTAKE;
INHIBITION EFFECT;
NANOSIZED MATERIALS;
PLGA-PEG-PLGA COPOLYMERS;
DISEASES;
NANOSTRUCTURED MATERIALS;
ONCOLOGY;
POLYETHYLENE GLYCOLS;
POLYETHYLENE OXIDES;
SOLUTIONS;
TUMORS;
COPOLYMERS;
ANTINEOPLASTIC AGENT;
DOXORUBICIN;
DRUG CARRIER;
MACROGOL DERIVATIVE;
NANOGEL;
PACLITAXEL;
POLY(LACTIC-GLYCOLIC ACID)-POLY(ETHYLENEGLYCOL) COPOLYMER;
POLYETHYLENEIMINE;
POLYGLACTIN;
POLY(LACTIC GLYCOLIC ACID) POLY(ETHYLENEGLYCOL) COPOLYMER;
ANIMAL;
BAGG ALBINO MOUSE;
BREAST NEOPLASMS;
CHEMISTRY;
DISEASE MODEL;
DRUG COMBINATION;
FEMALE;
HALF LIFE TIME;
MOUSE;
PATHOLOGY;
ARTICLE;
BREAST TUMOR;
ANIMALS;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
DISEASE MODELS, ANIMAL;
DOXORUBICIN;
DRUG CARRIERS;
DRUG THERAPY, COMBINATION;
FEMALE;
HALF-LIFE;
MICE;
MICE, INBRED BALB C;
PACLITAXEL;
POLYETHYLENE GLYCOLS;
POLYETHYLENEIMINE;
POLYGLACTIN 910;
|
EID: 84884864305
PISSN: 20403364
EISSN: 20403372
Source Type: Journal
DOI: 10.1039/c3nr02937a Document Type: Article |
Times cited : (33)
|
References (50)
|